25 May 2013
Keywords: ImClone, Waksal, Kadmon, Financing
Article | 17 February 2010
Samuel Waksal, the former chief executive of US biotechnology firm ImClone Systems, who due to an insider trading scandal led ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 February 2010
18 February 2010
24 May 2013
© 2013 thepharmaletter.com